1. A multicentre, open, investigator‐initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT). (1st October 2018) Authors: Kim, Y.C.; Yang, J.Y.; Yoon, J.S.; Jo, S.J.; Ahn, H.H.; Song, K.‐H.; Lee, D.‐Y.; Chung, K.‐Y.; Won, Y.‐H.; Kim, I.‐H. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Non‐melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population‐based cohort study. (26th November 2019) Authors: Yun, S.J.; Bae, J.M.; Kim, H.; Park, B.C.; Kim, J.S.; Seo, S.H.; Ahn, H.H.; Lee, D.Y.; Kim, Y.C.; Park, H.J.; Chung, K.Y. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 4(2020) Page Start: 746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗